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Abstract
Background: Internet-based cognitive behavioural therapy (iCBT) for depression is effective when guided by a
clinician, less so if unguided. Question: Would guidance from a technician be as effective as guidance from a
clinician?
Method: Randomized controlled non-inferiority trial comparing three groups: Clinician-assisted vs. technician-assisted vs.
delayed treatment. Community-based volunteers applied to the VirtualClinic (www.virtualclinic.org.au) research program,
and 141 participants with major depressive disorder were randomized. Participants in the clinician- and technician-assisted
groups received access to an iCBT program for depression comprising 6 online lessons, weekly homework assignments, and
weekly supportive contact over a treatment period of 8 weeks. Participants in the clinician-assisted group also received
access to a moderated online discussion forum. The main outcome measures were the Beck Depression Inventory (BDI-II)
and the Patient Health Questionnaire-9 Item (PHQ-9). Completion rates were high, and at post-treatment, both treatment
groups reduced scores on the BDI-II (p,0.001) and PHQ-9 (p,0.001) compared to the delayed treatment group but did not
differ from each other. Within group effect sizes on the BDI-II were 1.27 and 1.20 for the clinician- and technician-assisted
groups respectively, and on the PHQ-9, were 1.54 and 1.60 respectively. At 4-month follow-up participants in the technician
group had made further improvements and had significantly lower scores on the PHQ-9 than those in the clinician group. A
total of approximately 60 minutes of clinician or technician time was required per participant during the 8-week treatment
program.
Conclusions: Both clinician- and technician-assisted treatment resulted in large effect sizes and clinically significant
improvements comparable to those associated with face-to-face treatment, while a delayed treatment control group did
not improve. These results provide support for large scale trials to determine the clinical effectiveness and acceptability of
technician-assisted iCBT programs for depression. This form of treatment has potential to increase the capacity of existing
mental health services.
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Introduction
Depression and anxiety are both common and disabling [1–3].
Although effective treatments such as medication and cognitive
behavioural therapy (CBT) are available, less than half report
seeking any treatment and few receive specialized treatment from
trained mental health professionals [4]. Barriers to effective
treatment include limited availability of skilled clinicians, direct
and indirect costs of treatment, and difficulty attending treatment
during office hours.
One strategy for reducing barriers to effective treatment is the
development of computerized cognitive behavioural therapy
(CCBT) programs, which present structured sessions of CBT via
a computer interface [5,6]. Such programs may be accessed by
patients at primary or specialist care facilities, via the Internet or
DVD, and may be completed with the assistance of a clinician or
entirely self-guided. CCBT reduces the demands on clinician time
but the results of entirely self-guided treatment has been
significantly inferior [7–9].
A growing body of evidence indicates that clinician-assisted
Internet-based CBT (iCBT) can result in significant improvements
in patients with depressive [9–13] and anxiety disorders [14–27],
with results comparable to those obtained from good face-to-face
treatment. Recent studies of iCBT programs for generalized
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be reduced considerably by delegating the majority of patient
contact to a non-clinician (technician), without compromising
clinical outcomes or acceptability [16,28,29]. iCBT programs that
can be safely and effectively administered by technicians who are
supervised by clinicians, have considerable potential for enhancing
existing mental health services. An important question is whether
similar effects could be obtained from iCBT for depression when
administered by a technician.
The present CONSORT-Revised compliant randomized con-
trolled trial (RCT) [30] examined the clinical efficacy and
acceptability of clinician- and technician-assisted iCBT using the
Sadness program [12,13] for people with a DSM-IV [31] diagnosis
of depression. We hypothesised that participants in a technician-
assisted (TA) group would show similar clinical improvements on
measures of depression and disability as a clinician-assisted (CA)
group; that improvements would be sustained at follow-up; and
that both treatment groups would have better outcomes than a
delayed treatment (control) group.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Ethics
This study was approved by the St Vincent’s Hospital Human
Research Ethics Committee (HREC) and by the University of
New South Wales HREC. Written informed consent was obtained
from all participants.
Participants
Participants were recruited from June to July 2009 via a
website (www.virtualclinic.org.au) providing information about
common mental disorders including depression, and a link to
apply online to join a research treatment program. Participants
first applied online, completing questionnaires about severity of
symptoms, demographic details, and chronicity of symptoms (see
Table 1).
Exclusions were (i) not a resident of Australia; (ii) less than 18
years of age; (iii) no regular access to a computer, the Internet, and
use of a printer; (iv) currently participating in CBT; (v) using illicit
drugs or consuming more than three standard drinks/day; (vi)
experience of a psychotic mental illness (schizophrenia or bipolar
disorder) or current severe symptoms of depression (defined as a
total score .23 or responding .2 to Question 9 (suicidal ideation)
on the Patient Health Questionnaire - 9 Item (PHQ-9) [32]; (vii) a
total PHQ-9 score below 10; and (viii) if taking medication, had
been taking the same dose for less than 1 month or intending to
change that dose during the course of the program. Excluded
applicants immediately received an on-screen message and email
thanking them for their application, and encouraging them to
discuss their symptoms with their physician.
Participants who passed the screening phase were telephoned
for a diagnostic interview using the Mini International Neuropsy-
chiatric Interview Version 5.0.0 (MINI) [33] to determine whether
they met DSM-IV criteria for major depressive episode.
Participants who satisfied all criteria were informed of the study
design and invited to return a completed consent form by email.
The study was approved by the Human Research Ethics
Committees of St Vincent’s Hospital, Sydney, and the University
of New South Wales.
Interventions
Treatment group participants received access to the Sadness
program, an iCBT program with demonstrated efficacy at
reducing symptoms of depression [12–13]. The Sadness program
consists of six online lessons, printable summary and homework
assignments, automatic emails, and additional resource docu-
ments. The six online lessons represent best practice principles
used in CBT programs for depression including behavioural
activation, cognitive restructuring, problem solving, and assertive-
ness skills. Part of the content of each lesson is presented in the
form of an illustrated story about a woman with depression who,
with the help of a clinical psychologist, learns to gain mastery over
her symptoms. Automatic emails are sent to congratulate
participants for completing each lesson, to remind them to
complete materials, and to notify them of new resources. As people
progress through each lesson they have access to additional written
documents providing supplementary information about techniques
such as managing sleep problems, panic, and other common
comorbid symptoms. They are also provided with access to
vignettes written by previous participants about their own
experiences of managing depression during the Sadness program.
Participants are expected to complete the homework tasks prior to
completing the next lesson, and to complete all lessons within 8
weeks.
All participants began the 8-week treatment program at the
same time. Participants were advised to complete one lesson every
7–10 days and to complete the six lessons within 8 weeks of
starting. All participants received automatic emails informing
them when a lesson was to be completed, and reminder emails if
they had not completed a lesson within 7 days of notification.
Three staff conducted the study, with supervision from NT. The
technician (KM) was employed in an administrative role as a
Clinic Manager, Anxiety Disorders Clinic, Mental Health Service,
St Vincent’s Hospital, Sydney. She reported no prior experience
with research programs, no qualifications in health care or
counseling, and had no clinical duties in her usual role. The
clinician (MD) was a qualified and registered psychiatrist,
employed at the same unit as KM. The third staff member (KS)
was a research assistant, who provided administrative support to
the technician and clinician.
Technician-Assisted Treatment. During treatment the
technician provided TA group participants with weekly email or
telephone contact. The technician was given a guideline script
which identified the topics covered in each lesson of the program
and activities participants should be encouraged to practice for
each lesson. The technician was instructed to contact each TA
group participant weekly to provide encouragement and support,
and where possible to respond to participants’ general questions by
referring them to the materials in the Sadness program. The
technician was not permitted to provide clinical advice. The
technician received supervision from the clinician and was
instructed to inform the clinician of any perceived deterioration
in their participants’ mental health status, or of any concerns about
participants’ wellbeing. While conducting this research the
technician maintained her full-time role as a Clinic Manager.
Clinician-Assisted Treatment. CA group participants had
weekly email or telephone contact with the clinician and access to
an online discussion forum where they could post questions to the
clinician about the program content. Information posted on the
discussion forum could be read by other participants in the CA
group. The clinician was provided with the same guideline script
as the technician but was also instructed to answer participants’
questions via forum, email, or telephone. The clinician was
instructed to actively engage with each participant in treatment
Depression Internet Treatment
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Technician-
Assisted
Clinician-
Assisted
Control
Group Total
(n=41) (n=45–46) * (n=40)
(n=126–
127)
Variable Sub-variable n % n % n % n %
Gender Male 15 36.5 6 13.0 12 30.0 33 26.0
Female 26 63.4 40 86.9 28 70.0 94 74.0
Age Mean Age (SD) 44 (12.28) 40 (12.33) 46 (13.55) 43 (12.86)
Range 23–66 20–64 19–73 19–73
Marital Status Single/Never Married 10 24.4 17 36.9 11 27.5 38 29.9
Married/De Facto 18 43.9 20 43.5 22 55 60 47.3
Separated/Divorced 13 31.7 9 19.6 7 17.5 29 22.8
Education High school 4 9.75 9 19.6 7 17.5 20 15.7
Tertiary 27 65.85 26 56.5 24 60.0 77 60.6
Other Certificate 9 21.95 10 21.7 9 22.5 28 22.04
None 1 2.43 1 2.2 0 0 2 1.57
Employment Status Part time/student 10 24.4 20 41.3 17 42.5 47 37.0
Full time 18 43.9 13 30.4 15 37.5 46 36.2
Unemployed, retired
or disabled
13 31.7 13 28.3 8 20.0 34 26.8
Previously Discussed
Symptoms with
Health Professional
33 80.5 40 87.0 30 75.0 103 81.1
Taking Medication 26 63.4 26 46.5 22 55.0 74 58.3
Hours/Week of
Internet use.
0–10 19 46.3 23 50.0 19 47.5 61 48.0
11+ 22 53.7 23 50.0 21 52.5 66 52.0
Confidence using
computers and
Internet
Very Confident 24 58.5 25 55.6 22 55.0 71 55.9
Confident 8 19.5 16 35.6 9 22.5 33 26.9
Average 7 17.1 2 4.4 7 17.5 16 12.6
Mildly Confident 2 4.9 2 4.4 2 5.0 6 4.7
Not Confident 0 0.0 0 0.0 0 0.0 0 0.0
History of symptoms of
chronicity/severity of
depression: Age of onset
,12 6 14.6 5 10.9
13–21 18 43.9 23 50.0
.22 12 29.3 13 28.3
Did not respond 5 12.2 5 10.9
Number of episodes
of depression?
1 3 7.3 2 4.3
2–4 5 12.2 7 15.2
5–8 6 14.6 10 21.7
.8 22 53.7 22 47.8
Did not respond 5 12.2 5 10.9
Symptom free for 2
months or more in
past 2 years?
Yes 6 14.6 15 32.6
No 30 73.2 25 54.3
Did not respond 5 12.2 6 17.4
doi:10.1371/journal.pone.0010939.t001
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for overcoming hurdles to progress. Because of the clinical nature
of messages on the forum, the TA group did not have access to a
forum. The clinician and technician were instructed to spend no
more than 10 minutes in contact with each participant per week.
The total time required and nature of all contacts with participants
during treatment was recorded.
Control Group. Control group participants received the
clinician-assisted program described above, but began treatment
after the intervention groups completed the Sadness program.
Objectives
This study was a 3 group randomized controlled non-inferiority
trial to determine whether technician-assisted Internet treatment
was equivalent to clinician-assisted Internet treatment but superior
to delayed treatment (waitlist control).
Primary and Secondary Outcomes
Outcomes. One week prior to beginning the trial participants
completed the following questionnaires online: The PHQ-9, the
Beck Depression Inventory (second edition) (BDI-II) [34], the
Kessler 10 (K-10) [35], the Sheehan Disability Scales (SDS) [36],
and the Credibility/Expectancy Questionnaire (CEQ) [37,38].
The PHQ-9 is a 9-item measure with scores ranging from 0–27.
The BDI-II is a 21-item measure with scores ranging from 0–64. A
score of 10 on the PHQ-9 has been identified as providing an
important threshold for identifying DSM-IV congruent depression
[32,39]. The K-10 is a 10-item measure of psychological distress
with scores ranging from 10–50. The SDS is a 3 item measure of
disability with scores ranging from 0–30 and the CEQ is a widely
used measure of the expectancies or perception of treatment
credibility.
The PHQ-9, BDI-II, K-10 and SDS were re-administered one
week post-treatment and at four month post-treatment (follow-up),
while the PHQ-9 was also administered mid-treatment (at week 5).
All of these measures are considered reliable, valid, and
appropriate for clinical and research purposes, with recent
research indicating that online administration of questionnaires
results in acceptable reliability of responses [40,41]. Changes in
the PHQ-9 and BDI-II were considered the primary outcome
measures, while changes in the K-10, SDS and a treatment
satisfaction questionnaire (based on the CEQ) were the secondary
outcome measures. Follow-up results were not available for the
control group, who had started treatment by that time.
Sample Size and Randomization
Power calculations were based on a non-inferiority trial design
comparing parallel-groups. Alpha was set at 0.025, power at 90%,
and the mean minimal reliable change index for the PHQ-9 (based
on earlier findings) and standard deviations for each group were
expected to be equivalent (5 and 4, respectively). Using Table V
from Julious [42], the minimum sample size for each group was
identified as 39, but more were recruited to hedge against attrition.
The 141 people accepted into the program were randomised by
NT via a true randomisation process (www.random.org) to either
the CA (n=49), TA (n=47), or control groups (n=45) (see
Figure 1). Allocation preceded the diagnostic telephone call, and
self report measures precluded blinding.
Statistical Analysis
Group differences in demographic data, pre-treatment mea-
sures, and pre-treatment expectations were analyzed with one-way
analysis of variance (ANOVAs) and chi-square tests, followed by
t-tests with Bonferonni corrected p values. Changes in participants’
questionnaire scores from pre to post-treatment and from pre-
treatment to follow-up were analyzed using repeated measures
analyses of covariance (ANCOVAs). This approach is recom-
mended as a robust and reliable statistical strategy for analyzing
the results of RCTs [43,44]. Changes in questionnaire scores
between post-treatment and follow-up were analyzed using paired
samples t-tests. Effect sizes (Cohen’s d) were calculated both
within- and between-groups, based on the pooled standard
deviation. We also calculated 95% confidence intervals for the
between-group effect sizes between the two treatment groups for
each primary outcome measure. All post-treatment and follow-up
analyses adopt an intention-to-treat (ITT) design where missing
data is replaced by the last observation carried forward (LOCF).
Two scores (credibility and expectancy) were derived from the
CEQ by subjecting the scores to a linear transformation as
described in [37]. Change scores for the two primary outcome
measures, from pre to post and from pre to follow-up, were
calculated for each intervention group participant. Pearson
product moment correlations were calculated between these
change scores and the total number of contacts with participants
during the program and with the total time spent per participant,
to explore variables that may affect outcomes.
Three measures of clinical significance were employed. First,
pre-treatment and post-treatment PHQ-9 scores were compared
with optimum cut-offs for a probable diagnosis of depression using
evidence from the literature [32,39], to provide an index of
remission. This was defined as the proportion of participants who
initially scored above the optimum cut-off (PHQ-9 total score of
10 or more) and subsequently scored below this cut-off. Secondly,
an estimate of recovery was made by identifying the proportion of
participants in each group who demonstrated a significant
reduction in their symptoms (defined here, as a reduction of
50% of pre-treatment PHQ-9 scores) as described in recent
dissemination studies [45]. Thirdly, the percentage of participants
in each group who met criteria for both reliable and clinically
significant change on the BDI-II was calculated. This was defined
as the proportion of participants who met the criteria of
statistically reliable change as described in Jacobson and Truax
[46] and who also demonstrated a reduction in BDI-II scores of at
least 10 points, a magnitude of change that has been used in
similar research [47]. A reliable change index for the BDI-II was
calculated separately for each of the three groups using their pre-
treatment standard deviation, and a test-retest reliability coeffi-
cient of 0.93, as reported in the BDI-II manual [34].
Results
Participant Flow
Two hundred and fifty eight individuals expressed interest in the
study (Figure 1), 141 met all inclusion criteria, and were
randomized to one of the three groups. Forty one TA and 46
CA group participants completed the pre-treatment questionnaires
and began lesson 1 and are eligible for analysis, as are 40
control group participants, who completed the pre-treatment
questionnaires.
Baseline Characteristics
Characteristics of the groups are presented in Table 1. There
were no significant between-group differences in age, marital
status, education, employment, previous discussions of symptoms
with a health professional, use of medication, weekly use of the
internet, confidence in using computers, treatment expectancies,
or pre-treatment scores on the outcome measures. Treatment
Depression Internet Treatment
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participants reporting at least 5 previous episodes of depression
and fewer than 2 symptom free months in the past 2 years.
However, there were significantly fewer males in the CA group
(x
2=6.98, p,0.05).
Completion Rates
Thirty three (33/41, 80%) TA and 32/46 CA (70%) group
participants completed all 6 lessons within the required time. Post-
treatment data was collected from 37/41 (90%) TA, 41/46 (89%)
CA, and 39/40 (98%) control group participants. Follow-up data
(4 months post-treatment) were collected from 30/41 (73%) TA
and 38/46 (83%) CA group participants. In accordance with the
intention-to-treat and LOCF models, missing post-treatment or
follow-up data was addressed by replicating that participant’s last
observed score on that measure. Follow-up data were not available
for control group participants who had begun treatment by that
time.
Post-Treatment (11-Week) Outcomes
Primary Outcomes. Univariate ANCOVAs on post-
treatment PHQ-9 and BDI-II scores, controlling for pre-
treatment scores (see Table 2), revealed significant effects for
PHQ-9 (F2, 123=29.72, p,0.001) and BDI-II (F2, 123=21.72,
p,0.001) scores. Post-hoc pairwise comparisons revealed no
difference on either measure between treatment groups, but
significant differences between the treatment groups and the
control group (p,0.001).
Secondary Outcomes. Univariate ANCOVAs conducted on
the K-10 and SDS post-treatment scores, while controlling for pre-
treatment scores, revealed significant effects for K-10
(F2, 124=13.06, p,0.001) and SDS (F2, 124=63.87, p,0.001)
scores. Post-hoc pairwise comparisons revealed no difference on
either measure between treatment groups, but significant
differences between the treatment groups and the control group
(p,0.001).
Effect Sizes. Pre to post-treatment within-group effect sizes
on the BDI-II were 1.27 and 1.20 for the clinician and technician-
assisted groups, respectively, and on the PHQ-9 were 1.54 and
1.60, respectively (Table 2). The between-group effect size for the
treatment groups on the BDI-II was 0.07 (CI95%=20.35 to 0.49)
and on the PHQ-9 was 0.07 (CI95%=20.36 to 0.49). Large
(.0.80) within-group effect sizes (ESs) were found for both
treatment groups on the K-10 and SDS. Large ESs between each
treatment group and the control group were found for all
measures.
Clinical Significance: Remission, Recovery, and Reliable
Clinical Change. At pre-treatment 37/41 (90%) of TA group,
41/46 (89%) of CA group, and 31/40 (78%) of control group
participants had a PHQ-9 score of 10 or more, indicating a
persisting diagnosis of depression. At post-treatment (using the
ITT and LOCF design) 11/41 (27%) of TA group, 18/46 (39%) of
CA group, and 31/40 (78%) of control group participants
continued to have a PHQ-9 score above 9. Based on the criteria
for recovery (a reduction of pre-treatment PHQ-9 scores of at least
50%) at post-treatment, 61% of TA group, 43% of CA group and
3% of control group participants were classified as recovered.
Based on the criteria for reliable clinical change (statistically
reliable change and a reduction of pre-treatment BDI-II scores of
at least 10 points), 56% of TA group, 61% of CA group and 8% of
control group participants were classified as having achieved
reliable clinical change at post-treatment.
Treatment Satisfaction. Chi-squared tests and one-way
ANOVAs failed to reveal any differences between treatment
groups’ ratings of satisfaction with the program with respect to:
Figure 1. CONSORT-R participant flow chart.
doi:10.1371/journal.pone.0010939.g001
Table 2. Results of outcome measures: Means, standard deviations, confidence intervals and effect sizes (Cohen’s d) for each
group (intention to treat; last observation carried forward).
Group Pre Post Pre-Post Effect Sizes* Follow-Up Pre-Follow-Up Effect Sizes*
Outcome
Measure n Mean (SD) Mean (SD)
Mean
Difference
(95% CI)
Within
Group
TA
vs.
CA
vs.
Control Mean (SD)
Mean Difference
(95% CI) Within
TA
vs.
CA
PHQ-9 TA 41 14.20 (4.20) 7.59 (4.04) 6.61 (4.95–8.27) 1.60 0.07 1.27 6.49 (3.94) 7.71 (6.13–9.28) 1.89 0.46
CA 46 14.15 (4.39) 7.30 (4.48) 6.85 (5.40–8.29) 1.54 1.31 8.67 (5.42) 5.48 (3.75–7.20) 1.11
Control 40 13.35 (4.62) 12.98 (4.44) 0.38 (20.91–1.66) 0.08
BDI-II TA 41 27.15 (9.96) 15.29 (9.81) 11.85 (7.85–15.85) 1.20 0.07 1.09 11.66 (9.58) 15.49 (11.62–19.36) 1.59 0.40
CA 46 28.96 (11.51) 14.59 (11.12) 14.36 (10.62–18.11) 1.27 1.09 16.22 (13.16) 12.74 (8.83–16.65) 1.03
Control 40 26.33 (10.46) 26.15 (10.14) 0.18 (22.12–2.77) 0.02
K-10 TA 41 28.32 (6.39) 21.90 (7.01) 6.41 (3.85–8.98) 0.96 0.12 0.71 18.63 (7.64) 9.68 (6.71–12.66) 1.38 0.45
CA 46 29.07 (7.37) 21.07 (6.46) 8.00 (5.85–10.15) 1.15 0.86 22.04 (7.39) 7.02 (4.79–9.25) 0.95
Control 40 28.30 (7.29) 26.98 (7.29) 1.33 (20.52–3.17) 0.18
SDS TA 41 18.17 (6.69) 10.51 (8.03) 7.66 (4.87–10.45) 1.04 0.06 0.86 8.80 (7.56) 9.37 (6.64–12.09) 1.31 0.36
CA 46 18.22 (6.83) 11.00 (7.60) 7.22 (4.90–9.54) 1.00 0.80 11.65 (8.29) 6.56 (4.31–8.82) 0.87
Control 40 16.95 (7.05) 16.38 (5.65) 0.58 (21.37–2.52) 0.09
Pre: Pre treatment, Post: Post-treatment; Follow-up: 4 month follow-up; PHQ-9: Patient Health Questionnaire 9-Item; BDI-II: Beck Depression Inventory Second Edition;
K-10: Kessler 10-Item; SDS: Sheehan Disability Scale; TA: Technician assisted; CA: Clinician assisted. CI: Confidence Interval.
Note. *All effect sizes are absolute values.
doi:10.1371/journal.pone.0010939.t002
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(p=.82); and quality of the support they received from the
technician or clinician (p=.40). Overall, treatment group
participants reported an acceptable level of satisfaction with the
overall program, with 67/77 (87%) reporting being either very
satisfied or mostly satisfied, 10/77 (13%) neutral/somewhat dissatisfied,
and 0% reporting very dissatisfied. Most responding participants
(90%) rated the quality of the treatment modules as excellent or good;
81% rated the quality of Internet correspondence with the
clinician or technician as excellent or good, 14% rated it as
satisfactory, and 4% as unsatisfactory.
When asked to provide a rating from 1 to 10, where 10 indicates
a high level of agreement, the average participant rated the
treatment as logical (8/10); they reported feeling confident that the
treatment would be successful at teaching them techniques for
managing their symptoms (8/10); and they reported a high level of
confidence in recommending this treatment to a friend with
depression (8/10). No between treatment group differences were
found on these items.
Time/Contact Events Per Participant. One-way ANOVAs
did not reveal any difference in the total number of contacts
(telephone calls and emails) provided during the 8 week program to
each participant in the TA (mean, SD; 36.9, 5.3) and CA groups
(34.7, 6.3) (p=.10). One-way ANOVAs also failed to reveal any
difference in the total time spent by the technician (mean, SD,
61.0 mins, 9.8) or clinician (60.5, 19.0) with each participant during
the program (p=.88). These time estimates included time required
monitoring individual progress, reading and responding to emails,
discussing cases with the clinician, and attending weekly supervision
sessions. Conducting this research added approximately 5 hours per
week to the technician and the clinician’s existing workload. The
technician reported that most TA group participants were satisfied
during treatment but four (10%) participants were discussed with the
clinician because of concerns about their progress. The clinician
intervened in two of these cases, withdrawing them from the program
with their consent, and referring them to other services.
Time/Contact Events Per Participant and Change
Scores. No significant correlations were found between
change scores on the primary outcome measures and total time
or total contact events per participant (p range=0.48–0.97).
Follow-Up (4-Month) Outcomes
Primary Outcomes. Univariate ANCOVAs on follow-up
PHQ-9 and BDI-II scores, controlling for pre-treatment scores (see
Table 2), revealed a significant difference between the CA and TA
groups on the PHQ-9 (F1, 84=4.94, p,0.05) in favour of the TA
group, but no difference between groups on the BDI-II (p=.10).
Paired samples t-tests for each intervention group revealed that the
TA group made significant improvements between post-treatment
and follow-up assessments on the PHQ-9 (t(40)=2.48, p,0.05)
and BDI-II (t(40)=3.29, p,0.05). They also revealed that the CA
group deteriorated between post-treatment and follow-up
assessments on the PHQ-9 (t(45)=2.19, p,0.05) but had not
changed on the BDI-II (p=0.18).
Secondary Outcomes. Univariate ANCOVAs conducted on
the K-10, and SDS follow-up scores, while controlling for pre-
treatment scores, revealed a significant difference between the CA
and TA groups on the K-10 (F1, 84=4.18, p,0.05), but not on the
SDS.
Paired samples t-tests for each intervention group revealed that
the TA group made significant improvements between post-
treatment and follow-up assessments on the K-10 (t(40)=2.59,
p,0.05) and SDS (t(40)=2.04, p,0.05), with no significant
changes in CA group scores.
Effect Sizes. Pre to follow-up within-group effect sizes
(Table 2) on the BDI-II were 1.03 and 1.59 for the clinician and
technician-assisted groups, respectively, and 1.11 and 1.89 on the
PHQ-9, respectively. The between-group effect size for the
treatment groups on the BDI-II was 0.39 (CI95%=20.03 to
0.82) and on the PHQ-9 was 0.46 (CI95%=0.03 to 0.88). Large
(.0.80) within-group effect sizes (ESs) were found for both
treatment groups on the K-10 and SDS.
Clinical Significance: Remission, Recovery, and Reliable
Clinical Change. At follow-up (using the intention-to-treat and
LOCF design) 9/41 (22%) of TA group and 18/46 (39%) of CA
group participants continued to have a PHQ-9 score above 9.
Based on the criteria for recovery (a reduction of pre-treatment
PHQ-9 scores of at least 50%) at follow-up 66% of TA group and
43% of CA group participants were classified as recovered. Based
on the criteria for reliable clinical change (statistically reliable
change and a reduction of pre-treatment BDI-II scores of at least
10 points) 59% of TA group and 59% of CA group participants
were classified as having achieved reliable clinical change at
follow-up.
Discussion
This trial examined the relative efficacy and acceptability of
technician- vs. clinician-assisted Internet-based CBT for depres-
sion. At intake all participants met DSM-IV diagnosis of major
depressive episode, and the majority reported a history of multiple
depressive episodes. In addition to having access to the
components of the Sadness program, CA group participants had
weekly email or telephone contact with a clinician and access to an
online discussion forum. The clinician actively engaged in
treatment with CA group participants. TA group participants
also had access to the Sadness program and weekly email or
telephone contact with the technician, but did not have access to
an online forum. The technician provided support and encour-
agement, but did not provide clinical advice, and was instructed to
refer clinical questions or concerns to the clinician.
At post-treatment outcomes for both treatment groups were
superior to the control group and there were no differences
between the two treatment groups in either clinical outcomes or
acceptability. ESs within each treatment group on both depression
measures was equal to or greater than to 1.2 indicating that the
treatment effect was considerable. At post-treatment approximate-
ly 50% of participants in the treatment groups were classified as
recovered and/or had achieved reliable clinical change, providing
further evidence of clinical efficacy. Satisfaction with treatment
was high, even though the amount of contact time per participant
was approximately one hour. The total contact time required for
each group of more than 40 participants was estimated at
approximately 5 hours per week of clinician or technician time.
The automated email system facilitated the efficiency of contact
with participants and during treatment participants received more
than 30 contacts, prompts, and reminders.
At follow-up this pattern of results was generally stable,
although the technician-assisted group continued to make
improvements. At follow-up, the technician-assisted had signifi-
cantly lower PHQ-9 and K-10 scores than the clinician-assisted
group. At follow-up the between-group effect size for the
technician-assisted group (1.89) on the PHQ-9 was considerably
larger than for the clinician-assisted group (1.11).
Generalizability
These results support the study hypotheses and are consistent
with recent findings indicating that less than one hour of therapist
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clinical outcomes [11]. The present results also provide evidence
that a technician, when supervised by a clinician, can produce
results similar to those obtained by mental health professionals in
the treatment of depression. Similar outcomes have been reported
in I-CBT programs for treating social phobia [28,29] and
generalized anxiety disorder [16], providing evidence that, when
supervised by a clinician, I-CBT programs may be effectively and
safely administered by a non-clinician. The technician in the
present study was able to ‘‘step-up’’ participants to the clinician,
but did so with only 10% of participants. This indicates that the
majority found the intervention by the technician sufficient for
their needs, and demonstrates a potential model for integrating
clinician and technician support during iCBT programs. The
magnitude of clinical effects observed in this study are consistent
with those observed in previous evaluations of clinician-assisted
Internet-based treatment of depression [9–13]. These results are
also comparable to those observed in face-to-face treatment [48],
but considerably larger than those observed in self-guided
Internet-based treatment programs for depression [49,50].
An unexpected finding was that the technician-assisted group
continued to make improvements between post-treatment and
follow-up, while the clinician-guided group did not improve and
deteriorated on one of the primary outcome measures. It is
difficult to account for these findings as pre-treatment expectancies
and post-treatment satisfaction did not differ between intervention
groups, and no between-group differences were found in the total
number of contacts with participants or in the time spent on each
participant. Replication of this research design and detailed
analysis of the messages sent by the clinician and technician will be
conducted to explore the reliability of this finding and possible
reasons for differences.
Limitations
The relatively small sample size is one limitation of this study.
Other possible limitations include that the TA group had fewer
males than the other groups, and that the CA group had access to
more resources than the TA group. However, there is no
indication that these issues affected results. A fourth limitation is
the self-selecting nature of the sample. Those volunteering may
well be inherently motivated, but this does not challenge the
internal validity of the results. Another important potential
limitation is the use of a delayed treatment control group rather
than an attention-control placebo. This choice was grounded in
concerns about the impact of raised expectations of symptom
resolution in depressed participants placed in a placebo, attention-
control condition, and the difficulty contacting Internet partici-
pants should additional help have been required.
Conclusions
This randomized controlled trial found no difference between a
clinician- and technician-assisted Internet-based treatment pro-
gram for depression at post-treatment. Both conditions resulted in
large effect sizes, clinically significant improvements, and high
levels of acceptability, while a delayed treatment control group did
not improve. The technician-assisted group continued to improve
at the 4 month follow-up, while the clinician-assisted group did
not. These results demonstrate the potential of a new model of
providing evidence-based treatment for depression. The question
is not whether to accept such an innovative model of service
delivery, but how to do so in an ethical, competent, safe, and cost-
effective way, while also maintaining excellent clinical standards.
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